Arrowhead Pharmaceuticals
ARWR
#2017
Rank
ยฃ7.14 B
Marketcap
ยฃ51.65
Share price
1.20%
Change (1 day)
227.79%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): -ยฃ0.96

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ0.92. In 2024 the company made an earnings per share (EPS) of -ยฃ3.70 a decrease over its 2023 EPS that were of -ยฃ1.41.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ0.96-73.91%
2024-ยฃ3.70161.39%
2023-ยฃ1.4117.36%
2022-ยฃ1.2119.85%
2021-ยฃ1.0161.9%
2020-ยฃ0.62-216.67%
2019ยฃ0.53-210.77%
2018-ยฃ0.4838.3%
2017-ยฃ0.35-64.93%
2016-ยฃ0.99-16.25%
2015-ยฃ1.1828%
2014-ยฃ0.92-3.85%
2013-ยฃ0.96-31.58%
2012-ยฃ1.41331.82%
2011-ยฃ0.33-51.11%
2010-ยฃ0.67-79.07%
2009-ยฃ3.18-37.68%
2008-ยฃ5.10-16.87%
2007-ยฃ6.1438.33%
2006-ยฃ4.44122.22%
2005-ยฃ2.0042.11%
2004-ยฃ1.41533.33%
2003-ยฃ0.22-99.08%
2002-ยฃ24.0125%
2001-ยฃ19.2133.33%
2000-ยฃ14.41-120%
1999ยฃ72.04-400%
1998-ยฃ24.01-81.48%
1997-ยฃ129.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Alnylam Pharmaceuticals
ALNY
ยฃ0.06657-107.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ1.77-291.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-ยฃ2.13 130.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ7.72-935.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-ยฃ5.97 545.60%๐Ÿ‡บ๐Ÿ‡ธ USA